Hints and tips:
...Javier Quintanilla, an associate dean at Iese Business School in Barcelona, is profoundly deaf and has two cochlear implants....
...In 2017 Nurotron also expanded into Europe and Latin America. Cochlear is responding by investing more in China....
...Two of the biggest life science successes in the region are Cochlear, an Australia-listed company with a A$10.4bn market cap, which makes hearing implants; and ResMed (worth $13.6bn) which has pioneered...
...Sydney’s S&P/ASX 200 is down 0.9 per cent, held back from a further fall by a gain of 0.7 per cent from the health care segment – largely thanks to Cochlear (up 2.9 per cent) and CSL (up 1.4 per cent)....
...They did have one touchy subject to tackle: the birth father’s letter makes clear that he abandoned the baby because a doctor told him the child needed a cochlear implant and the birth family could not afford...
...There are also companies working in two clinical fields that have become established in relative isolation from the rest of bioelectronics research: cochlear implants translate sound into auditory signals...
...Cochlear climbed 7.6 per cent to A$62.52 after the maker of ear implants posted a narrower-than-expected first-half loss. The S&P/ASX 200 index fell 0.5 per cent to 4,274.2....
...The US company makes extremely small, technologically sophisticated, cochlear implants placed inside the ear, rather than worn externally....
...Interoperability represents a challenge to competition policies in Europe and America....
International Edition